|
Date Submitted:
12/11/07
Hits: 18 Rating:  0/5 based on 0 votes
Soy-Based Inhibitor Holds Promise as MS Treatment
Description:
A natural soy-based substance called Bowmann-Birk Inhibitor Concentrate (BBIC) improved the condition of animals with a disease similar to multiple sclerosis, a U.S. study says. One group of animals with the MS-like disease called autoimmune encephalomyelitis (EAE) received BBIC, while another group of animals with the same disease received an inert substance.
Read the Complete Article Similar content: Gene Holds Key to Blood Stem Cells, in Leukemia A Randomized, Controlled Pilot Study of a Home-Based Exercise Program for Individuals With Mild and Moderate Stroke , in Stroke Gout Drug Shows Promise, in Arthritis Hepatitis E Vaccine Shows Promise, in Hepatitis New Imaging Techniques Hold Promise for Variety of Diseases, in Alzheimers |
